Q1 FY26 Results
-
Finance & Investment
Supriya Lifescience Ltd. Reports Rs 145.07 Cr Revenue and 35.6% EBITDA Margin in Q1 FY26
New Delhi | 20, August 2025 : Supriya Lifescience Ltd., a global API manufacturer with operations in over 86 countries,…
Read More » -
Finance & Investment
SBI Cards Q1 FY26 Results : Revenue Jumps 12% to ₹5,035 Cr, PAT at ₹556 Cr
New Delhi | 28, July 2025 : SBI Cards and Payment Services Limited announced its financial results for the quarter…
Read More »
